CalciMedica CALC
NASDAQ CALC
$1.29 -0.08 (-5.84%)
As of: Nov 11, 2026 · 3:31 PM EST

CalciMedica (CALC) Return on Sales [ROS] (2024 - 2025)

Updated

CalciMedica (CALC) posted Return on Sales [ROS] of -30151.81% for Q2 2025, down 27777.63 percentage points from -2374.18% a year earlier and down 24754.84 percentage points from the prior quarter.

Analysis

CalciMedica (CALC) Return on Sales [ROS] (2024 - 2025) Analysis & Trends

For FY2024, CalciMedica's Return on Sales [ROS] came in at -2386.98%.

  • According to Business Quant data, Return on Sales [ROS] for the three prior quarters was -5396.97% (Q1 2025), -2884.11% (Q4 2024) and -2631.19% (Q3 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.35%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 36.01%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 29.12%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.79%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 41.71%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 32.98%
10 CalciMedica 9.45 Mn -4.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -30,151.81%
Mar 31, 2025 -5,396.97%
Dec 31, 2024 -2,884.11%
Sep 30, 2024 -2,631.19%
Jun 30, 2024 -2,374.18%
Mar 31, 2024 -1,878.50%
API Access

CalciMedica Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=CALC&period=max&api_key=YOUR_API_KEY